Monoclonal Antibodies
Anti-Smad1 Monoclonal Antibody for WB, IHC-P, IP, ELISA - Q15797
Item Number : CM0003193
Price varies based on specs and customizations
- Application
- WB, IHC-P, IP, ELISA
- Cross Reactivity
- Human, Mouse
- Protein Weight
- 52kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | [KO Validated] Smad1 Rabbit mAb |
| Remarks/Alias | BSP1, JV41, BSP-1, JV4-1, MADH1, MADR1, d1 |
| Species | Human |
| GeneID (Human) | 4086 |
| GeneID | 4086 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 20-240 of human Smad1 (NP_005891.1). |
| Source | Rabbit |
| Category | Monoclonal Antibodies |
| Application | WB, IHC-P, IP, ELISA |
| Cross Reactivity | Human, Mouse |
| SWISS | Q15797 |
| Protein Weight | 52kDa |
| Shipping | Ice bag |
Biological Background: Smad1 Function and Localization
- Transcriptional modulator involved in embryonic development, cell differentiation, and tissue homeostasis. Upon BMP ligand binding, SMAD1 is phosphorylated by type I BMP receptors, forms a complex with SMAD4, and translocates to the nucleus to regulate gene expression by binding Smad Binding Elements (SBEs). Related references: PMID:9335504, PMID:33667543
- Part of the SMAD family, acting as a critical intracellular mediator of the BMP signaling pathway, with key roles in odontogenesis and skeletal development.
- SMAD1/OAZ1/PSMB4 complex mediates the degradation of the CREBBP/EP300 repressor SNIP1, modulating transcriptional coactivator availability.
- Positively regulates BMP4-induced expression of the odontogenic regulator MSX1 following IPO7-mediated nuclear import.
- Shuttles between the cytoplasm and nucleus; undergoes nuclear accumulation upon pathway activation.
- Ubiquitously expressed, with highest levels observed in the heart and skeletal muscle.
- Subject to multiple post-translational modifications including phosphorylation, acetylation, and ubiquitination; contains a zinc-binding MH1 domain.
- Alternative splicing produces multiple protein isoforms, expanding functional diversity.
Experimental Guidance and Technical Tips
- The immunogen spans amino acids 20–240 of human Smad1, encompassing the conserved MH1 domain; cross-reactivity with mouse Smad1 is supported by sequence homology.
- For Western blot analysis, a band of approximately 52 kDa is expected. Include phosphatase inhibitors in lysis buffer to preserve phosphorylation-dependent signals.
- Immunoprecipitation and ELISA applications have been reported; optimal antibody concentration should be empirically determined for each assay.
- For immunohistochemistry (paraffin), antigen retrieval may be necessary; heart and skeletal muscle sections serve as positive control tissues.
- Consider the nuclear-cytoplasmic shuttling of Smad1 when interpreting localization data; BMP stimulation may alter subcellular distribution.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio supports diagnostic manufacturers and research laboratories with comprehensive IVD raw-material sourcing, including validated monoclonal antibodies like this Smad1 product for BMP/TGF-β pathway studies. Beyond catalog antibodies, we offer one-stop access to antibody pairs, ancillary reagents, and custom rare-target procurement—streamlining your development from concept to clinic.
Product Datasheet
Anti-Smad1 Monoclonal Antibody for WB, IHC-P, IP, ELISA - Q15797
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!